-
1
-
-
2342466734
-
Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030
-
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
-
(2004)
Diabetes Care
, vol.27
, pp. 1047-1053
-
-
Wild, S.1
Roglic, G.2
Green, A.3
Sicree, R.4
King, H.5
-
2
-
-
84975856269
-
Economic costs of diabetes in the U.S. in 2012
-
American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033-1046.
-
(2013)
Diabetes Care
, vol.36
, pp. 1033-1046
-
-
American Diabetes Association1
-
3
-
-
84922381210
-
Heart disease and stroke statistics - 2015 update: A report from the American Heart Association
-
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres J, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB. Heart disease and stroke statistics - 2015 update: a report from the American Heart Association. Circulation. 2015;131:e29-e322. doi: 10.1161/CIR.0000000000000152.
-
(2015)
Circulation
, vol.131
, pp. e29-e322
-
-
Mozaffarian, D.1
Benjamin, E.J.2
Go, A.S.3
Arnett, D.K.4
Blaha, M.J.5
Cushman, M.6
De Ferranti, S.7
Despres, J.8
Fullerton, H.J.9
Howard, V.J.10
Huffman, M.D.11
Judd, S.E.12
Kissela, B.M.13
Lackland, D.T.14
Lichtman, J.H.15
Lisabeth, L.D.16
Liu, S.17
Mackey, R.H.18
Matchar, D.B.19
McGuire, D.K.20
Mohler, E.R.21
Moy, C.S.22
Muntner, P.23
Mussolino, M.E.24
Nasir, K.25
Neumar, R.W.26
Nichol, G.27
Palaniappan, L.28
Pandey, D.K.29
Reeves, M.J.30
Rodriguez, C.J.31
Sorlie, P.D.32
Stein, J.33
Towfighi, A.34
Turan, T.N.35
Virani, S.S.36
Willey, J.Z.37
Woo, D.38
Yeh, R.W.39
Turner, M.B.40
more..
-
4
-
-
84896092380
-
Molecular mechanisms of diabetic cardiomyopathy
-
Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014;57:660-671. doi: 10.1007/s00125-014-3171-6.
-
(2014)
Diabetologia
, vol.57
, pp. 660-671
-
-
Bugger, H.1
Abel, E.D.2
-
5
-
-
84863283393
-
Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice
-
Battiprolu PK, Hojayev B, Jiang N, Wang ZV, Luo X, Iglewski M, Shelton JM, Gerard RD, Rothermel BA, Gillette TG, Lavandero S, Hill JA. Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice. J Clin Invest. 2012;122:1109-1118. doi: 10.1172/JCI60329.
-
(2012)
J Clin Invest
, vol.122
, pp. 1109-1118
-
-
Battiprolu, P.K.1
Hojayev, B.2
Jiang, N.3
Wang, Z.V.4
Luo, X.5
Iglewski, M.6
Shelton, J.M.7
Gerard, R.D.8
Rothermel, B.A.9
Gillette, T.G.10
Lavandero, S.11
Hill, J.A.12
-
6
-
-
0036143320
-
The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus
-
Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, Kelly DP. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest. 2002;109:121-130. doi: 10.1172/JCI14080.
-
(2002)
J Clin Invest
, vol.109
, pp. 121-130
-
-
Finck, B.N.1
Lehman, J.J.2
Leone, T.C.3
Welch, M.J.4
Bennett, M.J.5
Kovacs, A.6
Han, X.7
Gross, R.W.8
Kozak, R.9
Lopaschuk, G.D.10
Kelly, D.P.11
-
7
-
-
84928754600
-
Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor-α
-
Liu F, Song R, Feng Y, Guo J, Chen Y, Zhang Y, Chen T, Wang Y, Huang Y, Li C-Y, Cao C, Zhang Y, Hu X, Xiao R-P. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor-α. Circulation. 2015;131:795-804.
-
(2015)
Circulation
, vol.131
, pp. 795-804
-
-
Liu, F.1
Song, R.2
Feng, Y.3
Guo, J.4
Chen, Y.5
Zhang, Y.6
Chen, T.7
Wang, Y.8
Huang, Y.9
Li, C.-Y.10
Cao, C.11
Zhang, Y.12
Hu, X.13
Xiao, R.-P.14
-
8
-
-
58149326805
-
MG53 nucleates assembly of cell membrane repair machinery
-
Cai C, Masumiya H, Weisleder N, Matsuda N, Nishi M, Hwang M, Ko JK, Lin P, Thornton A, Zhao X, Pan Z, Komazaki S, Brotto M, Takeshima H, Ma J. MG53 nucleates assembly of cell membrane repair machinery. Nat Cell Biol. 2009;11:56-64. doi: 10.1038/ncb1812.
-
(2009)
Nat Cell Biol
, vol.11
, pp. 56-64
-
-
Cai, C.1
Masumiya, H.2
Weisleder, N.3
Matsuda, N.4
Nishi, M.5
Hwang, M.6
Ko, J.K.7
Lin, P.8
Thornton, A.9
Zhao, X.10
Pan, Z.11
Komazaki, S.12
Brotto, M.13
Takeshima, H.14
Ma, J.15
-
9
-
-
77954659591
-
TRIM72 negatively regulates myogenesis via targeting insulin receptor substrate-1
-
Lee CS, Yi JS, Jung SY, Kim BW, Lee NR, Choo HJ, Jang SY, Han J, Chi SG, Park M, Lee JH, Ko YG. TRIM72 negatively regulates myogenesis via targeting insulin receptor substrate-1. Cell Death Differ. 2010;17:1254-1265. doi: 10.1038/cdd.2010.1.
-
(2010)
Cell Death Differ
, vol.17
, pp. 1254-1265
-
-
Lee, C.S.1
Yi, J.S.2
Jung, S.Y.3
Kim, B.W.4
Lee, N.R.5
Choo, H.J.6
Jang, S.Y.7
Han, J.8
Chi, S.G.9
Park, M.10
Lee, J.H.11
Ko, Y.G.12
-
10
-
-
59149085706
-
MG53 regulates membrane budding and exocytosis in muscle cells
-
Cai C, Masumiya H, Weisleder N, Pan Z, Nishi M, Komazaki S, Takeshima H, Ma J. MG53 regulates membrane budding and exocytosis in muscle cells. J Biol Chem. 2009;284:3314-3322. doi: 10.1074/jbc.M808866200.
-
(2009)
J Biol Chem
, vol.284
, pp. 3314-3322
-
-
Cai, C.1
Masumiya, H.2
Weisleder, N.3
Pan, Z.4
Nishi, M.5
Komazaki, S.6
Takeshima, H.7
Ma, J.8
-
11
-
-
84883166199
-
MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling
-
Yi JS, Park JS, Ham YM, Nguyen N, Lee NR, Hong J, Kim BW, Lee H, Lee CS, Jeong BC, Song HK, Cho H, Kim YK, Lee JS, Park KS, Shin H, Choi I, Lee SH, Park WJ, Park SY, Choi CS, Lin P, Karunasiri M, Tan T, Duann P, Zhu H, Ma J, Ko YG. MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling. Nat Commun. 2013;4:2354. doi: 10.1038/ncomms3354.
-
(2013)
Nat Commun
, vol.4
, pp. 2354
-
-
Yi, J.S.1
Park, J.S.2
Ham, Y.M.3
Nguyen, N.4
Lee, N.R.5
Hong, J.6
Kim, B.W.7
Lee, H.8
Lee, C.S.9
Jeong, B.C.10
Song, H.K.11
Cho, H.12
Kim, Y.K.13
Lee, J.S.14
Park, K.S.15
Shin, H.16
Choi, I.17
Lee, S.H.18
Park, W.J.19
Park, S.Y.20
Choi, C.S.21
Lin, P.22
Karunasiri, M.23
Tan, T.24
Duann, P.25
Zhu, H.26
Ma, J.27
Ko, Y.G.28
more..
-
12
-
-
84874189145
-
Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders
-
Song R, Peng W, Zhang Y, Lv F, Wu HK, Guo J, Cao Y, Pi Y, Zhang X, Jin L, Zhang M, Jiang P, Liu F, Meng S, Zhang X, Jiang P, Cao CM, Xiao RP. Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. Nature. 2013;494:375-379. doi: 10.1038/nature11834.
-
(2013)
Nature
, vol.494
, pp. 375-379
-
-
Song, R.1
Peng, W.2
Zhang, Y.3
Lv, F.4
Wu, H.K.5
Guo, J.6
Cao, Y.7
Pi, Y.8
Zhang, X.9
Jin, L.10
Zhang, M.11
Jiang, P.12
Liu, F.13
Meng, S.14
Zhang, X.15
Jiang, P.16
Cao, C.M.17
Xiao, R.P.18
-
13
-
-
0036326045
-
Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart
-
Young ME, Guthrie PH, Razeghi P, Leighton B, Abbasi S, Patil S, Youker KA, Taegtmeyer H. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes. 2002;51:2587-2595.
-
(2002)
Diabetes
, vol.51
, pp. 2587-2595
-
-
Young, M.E.1
Guthrie, P.H.2
Razeghi, P.3
Leighton, B.4
Abbasi, S.5
Patil, S.6
Youker, K.A.7
Taegtmeyer, H.8
-
14
-
-
80052454265
-
ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1
-
Haemmerle G, Moustafa T, Woelkart G, Büttner S, Schmidt A, van de Weijer T, Hesselink M, Jaeger D, Kienesberger PC, Zierler K, Schreiber R, Eichmann T, Kolb D, Kotzbeck P, Schweiger M, Kumari M, Eder S, Schoiswohl G, Wongsiriroj N, Pollak NM, Radner FP, Preiss-Landl K, Kolbe T, Rülicke T, Pieske B, Trauner M, Lass A, Zimmermann R, Hoefler G, Cinti S, Kershaw EE, Schrauwen P, Madeo F, Mayer B, Zechner R. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1. Nat Med. 2011;17:1076-1085. doi: 10.1038/nm.2439.
-
(2011)
Nat Med
, vol.17
, pp. 1076-1085
-
-
Haemmerle, G.1
Moustafa, T.2
Woelkart, G.3
Büttner, S.4
Schmidt, A.5
Van De Weijer, T.6
Hesselink, M.7
Jaeger, D.8
Kienesberger, P.C.9
Zierler, K.10
Schreiber, R.11
Eichmann, T.12
Kolb, D.13
Kotzbeck, P.14
Schweiger, M.15
Kumari, M.16
Eder, S.17
Schoiswohl, G.18
Wongsiriroj, N.19
Pollak, N.M.20
Radner, F.P.21
Preiss-Landl, K.22
Kolbe, T.23
Rülicke, T.24
Pieske, B.25
Trauner, M.26
Lass, A.27
Zimmermann, R.28
Hoefler, G.29
Cinti, S.30
Kershaw, E.E.31
Schrauwen, P.32
Madeo, F.33
Mayer, B.34
Zechner, R.35
more..
-
15
-
-
38649116056
-
Selective versus total insulin resistance: A pathogenic paradox
-
Brown MS, Goldstein JL. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 2008;7:95-96. doi: 10.1016/j.cmet.2007.12.009.
-
(2008)
Cell Metab
, vol.7
, pp. 95-96
-
-
Brown, M.S.1
Goldstein, J.L.2
-
16
-
-
27744495040
-
A putative stimulatory role for activator turnover in gene expression
-
Lipford JR, Smith GT, Chi Y, Deshaies RJ. A putative stimulatory role for activator turnover in gene expression. Nature. 2005;438:113-116. doi: 10.1038/nature04098.
-
(2005)
Nature
, vol.438
, pp. 113-116
-
-
Lipford, J.R.1
Smith, G.T.2
Chi, Y.3
Deshaies, R.J.4
-
17
-
-
0032907106
-
The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily
-
Nawaz Z, Lonard DM, Smith CL, Lev-Lehman E, Tsai SY, Tsai MJ, O'Malley BW. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol. 1999;19:1182-1189.
-
(1999)
Mol Cell Biol
, vol.19
, pp. 1182-1189
-
-
Nawaz, Z.1
Lonard, D.M.2
Smith, C.L.3
Lev-Lehman, E.4
Tsai, S.Y.5
Tsai, M.J.6
O'Malley, B.W.7
-
18
-
-
84861869979
-
Ubiquitin and proteasomes in transcription
-
Geng F, Wenzel S, Tansey WP. Ubiquitin and proteasomes in transcription. Annu Rev Biochem. 2012;81:177-201. doi: 10.1146/annurev-biochem-052110-120012.
-
(2012)
Annu Rev Biochem
, vol.81
, pp. 177-201
-
-
Geng, F.1
Wenzel, S.2
Tansey, W.P.3
-
19
-
-
33749188883
-
FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP
-
van der Horst A, de Vries-Smits AM, Brenkman AB, van Triest MH, van den Broek N, Colland F, Maurice MM, Burgering BM. FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat Cell Biol. 2006;8:1064-1073. doi: 10.1038/ncb1469.
-
(2006)
Nat Cell Biol
, vol.8
, pp. 1064-1073
-
-
Van Der Horst, A.1
De Vries-Smits, A.M.2
Brenkman, A.B.3
Van Triest, M.H.4
Van Den Broek, N.5
Colland, F.6
Maurice, M.M.7
Burgering, B.M.8
-
20
-
-
77954757865
-
Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair
-
Wang X, Xie W, Zhang Y, Lin P, Han L, Han P, Wang Y, Chen Z, Ji G, Zheng M, Weisleder N, Xiao RP, Takeshima H, Ma J, Cheng H. Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair. Circ Res. 2010;107:76-83. doi: 10.1161/CIRCRESAHA.109.215822.
-
(2010)
Circ Res
, vol.107
, pp. 76-83
-
-
Wang, X.1
Xie, W.2
Zhang, Y.3
Lin, P.4
Han, L.5
Han, P.6
Wang, Y.7
Chen, Z.8
Ji, G.9
Zheng, M.10
Weisleder, N.11
Xiao, R.P.12
Takeshima, H.13
Ma, J.14
Cheng, H.15
-
21
-
-
79958809482
-
MG53 participates in ischaemic postconditioning through the RISK signalling pathway
-
Zhang Y, Lv F, Jin L, Peng W, Song R, Ma J, Cao CM, Xiao RP. MG53 participates in ischaemic postconditioning through the RISK signalling pathway. Cardiovasc Res. 2011;91:108-115. doi: 10.1093/cvr/cvr029.
-
(2011)
Cardiovasc Res
, vol.91
, pp. 108-115
-
-
Zhang, Y.1
Lv, F.2
Jin, L.3
Peng, W.4
Song, R.5
Ma, J.6
Cao, C.M.7
Xiao, R.P.8
-
22
-
-
77953812567
-
MG53 constitutes a primary determinant of cardiac ischemic preconditioning
-
Cao CM, Zhang Y, Weisleder N, Ferrante C, Wang X, Lv F, Zhang Y, Song R, Hwang M, Jin L, Guo J, Peng W, Li G, Nishi M, Takeshima H, Ma J, Xiao RP. MG53 constitutes a primary determinant of cardiac ischemic preconditioning. Circulation. 2010;121:2565-2574. doi: 10.1161/CIRCULATIONAHA.110.954628.
-
(2010)
Circulation
, vol.121
, pp. 2565-2574
-
-
Cao, C.M.1
Zhang, Y.2
Weisleder, N.3
Ferrante, C.4
Wang, X.5
Lv, F.6
Zhang, Y.7
Song, R.8
Hwang, M.9
Jin, L.10
Guo, J.11
Peng, W.12
Li, G.13
Nishi, M.14
Takeshima, H.15
Ma, J.16
Xiao, R.P.17
-
23
-
-
84920146429
-
Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury
-
Liu J, Zhu H, Zheng Y, Xu Z, Li L, Tan T, Park KH, Hou J, Zhang C, Li D, Li R, Liu Z, Weisleder N, Zhu D, Lin P, Ma J. Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury. J Mol Cell Cardiol. 2014;80C:10-19. doi: 10.1016/j.yjmcc.2014.12.010.
-
(2014)
J Mol Cell Cardiol
, vol.80 C
, pp. 10-19
-
-
Liu, J.1
Zhu, H.2
Zheng, Y.3
Xu, Z.4
Li, L.5
Tan, T.6
Park, K.H.7
Hou, J.8
Zhang, C.9
Li, D.10
Li, R.11
Liu, Z.12
Weisleder, N.13
Zhu, D.14
Lin, P.15
Ma, J.16
-
24
-
-
84904680983
-
Treatment of acute lung injury by targeting MG53-mediated cell membrane repair
-
Jia Y, Chen K, Lin P, Lieber G, Nishi M, Yan R, Wang Z, Yao Y, Li Y, Whitson BA, Duann P, Li H, Zhou X, Zhu H, Takeshima H, Hunter JC, McLeod RL, Weisleder N, Zeng C, Ma J. Treatment of acute lung injury by targeting MG53-mediated cell membrane repair. Nat Commun. 2014;5:4387. doi: 10.1038/ncomms5387.
-
(2014)
Nat Commun
, vol.5
, pp. 4387
-
-
Jia, Y.1
Chen, K.2
Lin, P.3
Lieber, G.4
Nishi, M.5
Yan, R.6
Wang, Z.7
Yao, Y.8
Li, Y.9
Whitson, B.A.10
Duann, P.11
Li, H.12
Zhou, X.13
Zhu, H.14
Takeshima, H.15
Hunter, J.C.16
McLeod, R.L.17
Weisleder, N.18
Zeng, C.19
Ma, J.20
more..
-
25
-
-
84862907349
-
Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy
-
Weisleder N, Takizawa N, Lin P, Wang X, Cao C, Zhang Y, Tan T, Ferrante C, Zhu H, Chen PJ, Yan R, Sterling M, Zhao X, Hwang M, Takeshima M, Cai C, Cheng H, Takeshima H, Xiao RP, Ma J. Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy. Sci Transl Med. 2012;4:139ra85. doi: 10.1126/scitranslmed.3003921.
-
(2012)
Sci Transl Med
, vol.4
, pp. 139ra85
-
-
Weisleder, N.1
Takizawa, N.2
Lin, P.3
Wang, X.4
Cao, C.5
Zhang, Y.6
Tan, T.7
Ferrante, C.8
Zhu, H.9
Chen, P.J.10
Yan, R.11
Sterling, M.12
Zhao, X.13
Hwang, M.14
Takeshima, M.15
Cai, C.16
Cheng, H.17
Takeshima, H.18
Xiao, R.P.19
Ma, J.20
more..
|